All In Biotech

Free tool

FAERS Monitor: Idose Tr

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 218010 or its brand name (Idose Tr, Travoprost). Reports on generic versions are filed under their own applications.

Reports

118

Serious

19

16% of reports

Hospitalization

1

Death reported

0

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • medical device removal32
  • intraocular pressure increased27
  • device dislocation18
  • eye pain17
  • eye inflammation13
  • cystoid macular oedema12
  • iritis12
  • photophobia8
  • vision blurred7
  • corneal oedema6
  • hyphaema5
  • ocular hyperaemia5
  • medical device repositioning4
  • visual acuity reduced4
  • anterior chamber cell3

Reports by year received

View as table
YearReports
202410
202547
202661

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,041 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
medical device repositioningSignal425489.29081.568,297
medical device removalSignal323362.52492.0102,283
hyphaemaSignal51725.6728.76,913
cystoid macular oedemaSignal121142.5667.012,490
anterior chamber cellSignal3752.8245.71,557
iritisSignal12706.4412.77,733
corneal oedemaSignal6478.6219.22,396
intraocular pressure increasedSignal27377.4270.89,747
eye inflammationSignal13243.2145.62,895
photophobiaSignal875.838.8519
device dislocationSignal1873.848.21,223
eye painSignal1753.734.6830
visual acuity reducedSignal421.58.259
ocular hyperaemiaSignal518.88.067
vision blurredSignal79.14.443

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.